Q3 2024 Avadel Pharmaceuticals PLC Earnings Call Transcript
(Operator Instructions) Good day, everyone, and welcome to today's Avadel Pharmaceuticals 3Q '24 Earnings Call. (Operator Instructions) Please note, this call is being recorded (Operator Instructions). It is now my pleasure to turn the conference over to Austin Murtagh with Precision AQ.
Good morning, and thank you for joining us on our conference call to discuss Avadel's Third Quarter 2024 results. As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. These risks and uncertainties are described in Avadel's public filings under the Exchange Act included in the Form 10-K for the year ended December 31, 2023, which was filed on February 29, 2024, and subsequent SEC filings.
Except as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |